Journal editors question sale of diet pill Meridia

(AP) -- Editors of a top medical journal are questioning whether the diet pill Meridia should stay on the market even if it's restricted to people without heart disease.

A new study shows the appetite suppressant raises the risk of and stroke in people with heart problems.

The strongly worded editorial in Thursday's comes two weeks before government advisers review the prescription drug.

The weight-loss pill has already been pulled in Europe and U.S. drug regulators have added stronger warnings to the label.

The maker of the diet pill, Abbott Laboratories, says it's still appropriate for obese people who don't have and who can't lose weight through diet and exercise.

©2010 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Citation: Journal editors question sale of diet pill Meridia (2010, September 1) retrieved 28 March 2024 from https://medicalxpress.com/news/2010-09-journal-editors-sale-diet-pill.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Experimental diet pill shows promise, little risk

 shares

Feedback to editors